Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:1102-1106 (25 November), doi:10.1136/bmj.39022.423588.DE
Timothy J Wilt, professor of medicine1, Ian M Thompson, professor and chair, department of urology2
1 Minneapolis VA Center for Chronic Disease Outcomes Research, 1 Veterans Drive (111-0), Minneapolis, MN 55417, USA, 2 University of Texas Health Science Center, San Antonio, USA
Correspondence to: T J Wilt Tim.wilt@med.va.gov
| The first 150 words of the full text of this article appear below. |
Prostate cancer is the most commonly diagnosed cancer in United Kingdom men.w1 In 2002 it was diagnosed in 32 000 men, and more than 10 000 deaths were attributed to it. Its incidence increased with the introduction of the prostate specific antigen (PSA) blood test, and disease specific mortality has declined. This review provides evidence about risk factors, prevention, detection, natural course, and treatment, with a focus on clinically localised disease, to guide primary care doctors.
|
Read all Rapid Responses